White matter connectome in patients with genetic dystonia
Silvia Basaia1, Federica Agosta1, Alexandra Tomic2, Elisabetta Sarasso1, Nikola Kresojević2, Sebastiano Galantucci1, Marina Svetel2, Vladimir S. Kostic2, and Massimo Filippi1,3

1Neuroimaging Research Unit, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy, 2Clinic of Neurology, Faculty of Medicine, University of Belgrade, Belgrade, Yugoslavia, 3Department of Neurology, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy

Synopsis

We investigated structural neural pathways in asymptomatic and symptomatic mutation carriers with several dystonia (DYT) genotypes using a network approach. Both symptomatic and asymptomatic mutation carriers showed an alteration of structural connectivity compared to controls, beyond the basal ganglia/sensorimotor cortex regions. No differences were found between symptomatic and asymptomatic DYT subjects. The structural connectome offered the possibility of identifying genotype-related trait characteristics, even in the preclinical phase of the disease, providing new insights into understanding DYT generation.

Purpose

Primary dystonia (DYT) has traditionally been attributed to basal ganglia dysfunction. Recent studies expanded this picture suggesting primary DYT as a circuit disorder. This study investigated structural neural pathways in clinically manifesting and non-manifesting individuals with several DYT genotypes using a network approach.

Methods

This study included a large series of clinically manifesting and non-manifesting DYT mutation carriers. Specifically, we enrolled 9 asymptomatic mutation carriers (4 DYT1, 4 DYT6, 1 DYT10) and 26 symptomatic mutation carriers (7 DYT1, 7 DYT6, 9 DYT5 or dopa-responsive dystonia, 1 DYT18, 1 DYT10, and 1 DYT25). 37 age- and sex-matched healthy controls were also studied. Subjects underwent 3D T1 weighted and diffusion tensor (DT) MRI. The human macroscale connectome – a comprehensive map describing all neural connections between large-scale brain regions – was constructed from DT MRI. Tissue segmentation was performed on T1 images using Freesurfer. Parcellation of the segmented gray matter mask into 83 distinct brain regions was based on Desikan atlas, including basal ganglia. Tractography was performed to reconstruct the white matter tracts forming the structural brain network. From the total collection of reconstructed streamlines those connecting each couple of nodes i and j were selected. Then, from the selected fiber streamlines, the average fractional anisotropy (FA) and mean diffusivity (MD) values were computed. This value entered into cell c(i,j) in the matrix. The affected structural connections in patients with manifesting and non-manifesting DYT relative to healthy controls and each other were investigated using Network-Based Statistic (p<0.01, 10.000 permutations).

Results

Compared to controls, asymptomatic mutation carriers showed a basal ganglia/frontal subnetwork characterized by decreased FA and increased MD including the left putamen, precentral gyrus, middle and superior frontal gyri, middle temporal, and insula (Fig. 1). Clinically manifesting DYT mutation carriers relative to controls showed an altered subnetwork characterized by increased MD connecting left putamen, middle and superior frontal gyri, orbitofrontal cortex, middle temporal, insula and right anterior cingulate cortex (Fig. 2). No differences were found between symptomatic and asymptomatic DYT subjects. A trend toward a greater disconnection was observed in symptomatic DYT1 relative to DYT6 subjects.

Conclusions

Our findings suggest that structural brain abnormalities in both clinically manifesting and non-manifesting DYT mutation carriers are distributed at a network level, beyond the basal ganglia/sensorimotor cortex regions. Studying of asymptomatic mutation carriers offered the possibility of identifying genotype-related trait characteristics without the confound of clinical symptoms providing new insights into understanding DYT generation.

Acknowledgements

No acknowledgement found.

References

No reference found.

Figures

Figure 1: Subnetwork showing altered fractional anisotropy (FA) and mean diffusivity (MD) in asymptomatic DYT mutation carriers compared to controls. Abbreviations: DYT-A= asymptomatic DYT mutation carriers; FA= fractional anisotropy; HC= healthy controls; L= left; MD= mean diffusivity; R= right.

Figure 2: Subnetwork showing altered mean diffusivity (MD) in patients with symptomatic DYT mutation carriers compared to controls. Abbreviations: DYT-S= symptomatic DYT mutation carriers; HC= healthy controls; L= left; MD= mean diffusivity; R= right.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
1239